Clitoral HOOD granulosa cell tumor; case report and review of literature

doi:10.15406/ogij.2021.12.00586

eISSN: 2377-4304

Obstetrics & Gynecology International Journal

Case Report Volume 12 Issue 4

Clitoral HOOD granulosa cell tumor; case report and review of literature

Neil Patel MD,

Verify Captcha

Regret for the inconvenience: we are taking measures to prevent fraudulent form submissions by extractors and page crawlers. Please type the correct Captcha word to see email ID.

Alexandra Hamilton MD, Natasha Fievre MD FACOG

Department of Obstetrics and Gynecology, The Brooklyn Hospital Center, USA

Correspondence: Neil Patel, MD, Department of Obstetrics and Gynecology, The Brooklyn Hospital Center, 121 Dekalb Ave.Bk, NY, 11201, USA, Tel 303-919-7668

Received: July 21, 2021 | Published: July 30, 2021

Citation: Patel N, Hamilton A, Fievre N. Clitoral HOOD granulosa cell tumor; case report and review of literature. Obstet Gynecol Int J. 2021;12(4):253-254. DOI: 10.15406/ogij.2021.12.00586

Download PDF

Abstract

Background: Granulosa Cell tumors (GCT) are a sex-cord stroma tumor comprising of 1-2% of ovarian malignancies. Derived from Schwann cells, GCTs are comprised of granulosa cells, a cell of the ovarian stroma. Patients with these tumors present with signs of increased estrogen such as vaginal bleeding, irregular menstruation and rarely hirsutism and virilization.^8,10-12 The majority of GCTs are found in the skin, subcutaneous tissue and submucosa with a handful of case reports discussing primary GCTs in the clitoris.^3,7 Surgery is required for definitive tissue diagnosis and staging. In this case report, we present a case with tissue diagnosis for granulosa cell tumor found on the clitoral hood.

Case: A 56-year-old, female, G6P3033 initially presented for evaluation of persistent clitoral cyst for >2 years Initial evaluation was significant for 1 cm clitoral cyst that was firm, smooth and fluctuant with no irregular borders; with worsening vulvodynia. The patient underwent clitoral hood mass excision. The mass was excised entirely and the post-operative recovery was uncomplicated. Pathology findings were significant for completely excised granulosa cell tumor; margins were negative for tumor. Immunohistochemical stain was positive for CD56, CD68, Vimentin, and S-100, and negative for AE1/13, CD31, CD34, SMA, and Desmin.

Conclusion: When evaluating chronic, persistent, or recurrent masses, it is important to take into consideration both benign and malignant causes. Definitive diagnosis is established pathologically. Patients with confirmed GCT should be thorough evaluated pre-operatively with blood work and appropriate imaging. Upon diagnosis, patient with GCT should be regularly followed for recurrence and surveillance.

Keywords: granulosa cell tumor, clitoral hood mass, sex-cord stroma tumor

Abbreviations

GCT, granulosa cell tumor

Introduction

Granulosa Cell tumors (GCT) are a sex-cord stroma tumor comprising of 1-2% of ovarian malignancies. GCTs can occur at any age but have a predilection for postmenopausal women in the fifth decade of life.^1–3 Derived from Schwann cells, GCTs are comprised of granulosa cells, a cell of the ovarian stroma. These cells are hormonally active and secrete sex steroids such as estrogen. Patients with these tumors present with signs of increased estrogen such as vaginal bleeding, irregular menstruation and rarely hirsutism and virilization.^1–4 The majority of GCTs are found in the skin, subcutaneous tissue and submucosa with a handful of case reports discussing primary GCTs in the clitoris.^5,6 Most cases are benign with only 2% being malignant.^5,7 There is no known genetic predisposition to GCT. The typical gross appearance of GCT is of tan-yellow appearance owing to steroid production. Microscopically, GCT is made up of granulosa cells - small, pale, round cells with “coffee bean” nuclei and eosinophilic cytoplasmic granules.^2,3,6,8 Surgery is required for definitive tissue diagnosis and staging. In this case report, we retrospectively studied the clinical presentation and histopathology in a patient with a clitoral hood granulosa tumor. The literature is limited on primary granulosa cell tumors of the clitoral hood, which is evidence to the rarity of the finding.

Case presentation

Initial presentation

A 56-year-old, female, G6P3033 initially presented to the clinic for evaluation of persistent clitoral cyst for >2years. Patient stated the cyst had been growing over time, resulting in worsening vulvodynia. Initial evaluation was significant for 1 cm clitoral cyst that was firm, smooth and fluctuant with no irregular borders. The patient endorsed mild tenderness. Exam showed grossly normal vaginal tissue and was negative for edema, erythema and significant skin discoloration. Uterus and adnexal masses were not palpable. Patient denied weight loss, fatigue, cachexia, fever which are clinical signs and symptoms of malignancy.

Gynecologic history: Uterine fibroids, dysmenorrhea, who underwent laparoscopic hysterectomy (without oophorectomy, secondary to uterine fibroids), no history of abnormal pap smears.

Obstetric history: 3 Full term deliveries via cesarean section. 3 early trimester losses.

Medical history: Hypertension, Hypercholesterolemia, Diabetes.

Mellitus surgical history: Cesarean Section (x3), Dilation and Curettage (x3), Laparoscopic Hysterectomy.

Familial history: patient denies significant family history, abnormal familial gynecologic disorders, diseases, cancers.

Medications: Metoprolol, Simvastatin, Metformin, Vaseretic.

Operative findings

Patient underwent elective surgical management for clitoral hood mass excision with no significant intra-operative findings. Evaluation was consistent with initial presentation. The mass was excised entirely, and the post-operative recovery was uncomplicated.

Pathology findings

Pathology findings were significant for completely excised granulosa cell tumor; margins were negative for tumor. Immunohistochemical stain was positive for CD56, CD68, Vimentin, and S-100, and negative for AE1/13, CD31, CD34, SMA, and Desmin.

Discussion

Granulosa cell tumors are mostly asymptomatic, benign, slow growing tumors with preponderance in adult females.⁹ Most benign GCTs measure < 3cm in size, and commonly found in women aged 40-60years.³ Granulosa cell tumors can be found in skin, subcutaneous tissue and submucosa and the majority of lesions present as a single mass. Ovarian GCTs often present with signs of excess estrogen and when large, may cause obstructive symptoms.³ Vulvar GCTs often present as a slowly enlarging subcutaneous, mobile mass that may present with pruritis and hyperpigmentation.¹⁰ Microscopically, GCTs are distinguished by the presence of granulosa cells - small, pale, round cells with coarse, eosinophilic cytoplasmic granules which stain positive for neural markers such as S100.^3,7,9 To date, few cases of clitoral granulosa cell tumors have been reported.

Our patient presented with a clitoral mass that persisted for >2years. On observation the mass initially was 1cm x 1cm, firm with mild tenderness. Prior to the excision, patient underwent transvaginal ultrasound evaluation one month prior to procedure; status post-hysterectomy, both ovaries identified, no cysts or adnexal masses noted. The mass excised was sent to pathology and was significant for granulosa cell tumor with clear margins. Immunohistochemistry stained positive for S-100 protein, CD68 and vimentin, which further strengthened the schwannian origin.^5,8,9 This condition requires differentiation from other benign disease of the external genitalia.

The gold standard of treatment is complete resection with routine follow up for recurrence.^3,5 The recurrence rate with negative resection margins for benign GCTs is 2%-8%. In addition, extragenital areas should also be evaluated as studies support cases of multiple GCTs at various sites.^3,5,11 There is ongoing debate regarding treatment for GCTs as most studies indicate that radiation and chemotherapy have not been successful.^10,12 A study by Golchai J et al. however, found that neoadjuvant chemotherapy successfully treated GCT of the uterine cervix.¹¹This discrepancy illustrates the need for more research and development of treatment guidelines for GCTs.

Conclusion

When evaluating chronic, persistent, or recurrent masses, it is important to take into consideration both benign and malignant causes. Definitive diagnosis is established pathologically. Patients with confirmed GCT should be thorough evaluated pre-operatively with blood work and appropriate imaging. Upon diagnosis, patient with GCT should be regularly followed for recurrence and surveillance.